Exposure to monomethylarsonous acid (MMAIII) leads to altered selenoprotein synthesis in a primary human lung cell model

Toxicology and Applied Pharmacology

Volumn 239, Issue 2, 2009, Pages 130-136

  Meno, Sarah R ^a   Nelson, Rebecca ^a   Hintze, Korry J ^b   Self, William T ^a  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^b UTAH STATE UNIVERSITY   (United States)

Author keywords

Antioxidant response element; Arsenic; Carcinogenesis; Monomethylarsonous acid; Selenium; Thioredoxin reductase

Indexed keywords

ANTIOXIDANT; GLUTATHIONE PEROXIDASE; LUCIFERASE; MESSENGER RNA; METHANEARSONIC ACID; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SELENIUM; SELENOPROTEIN; THIOREDOXIN REDUCTASE;

ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CARCINOGENICITY; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; ENZYME SYNTHESIS; FIBROBLAST CULTURE; GENE MUTATION; HUMAN; HUMAN CELL; ISOTOPE LABELING; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; TOXICOKINETICS;

ANIMALS; ARSENICALS; CELL CULTURE TECHNIQUES; CELL LINE; CELL SURVIVAL; FIBROBLASTS; GENE EXPRESSION; GLUTATHIONE PEROXIDASE; HUMANS; LUNG; PROMOTER REGIONS, GENETIC; RATS; RECOMBINANT FUSION PROTEINS; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SELENOPROTEINS; THIOREDOXIN REDUCTASE 1; TRANSCRIPTIONAL ACTIVATION;

RATTUS;

EID: 68949194237     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.11.011     Document Type: Article

References (57)

1. Aono J., Yanagawa T., Itoh K., Li B., Yoshida H., Kumagai Y., Yamamoto M., and Ishii T. Activation of Nrf2 and accumulation of ubiquitinated A170 by arsenic in osteoblasts. Biochem. Biophys. Res. Commun. 305 (2003) 271-277
2. Arner E.S., and Holmgren A. The thioredoxin system in cancer. Semin. Cancer Biol. 16 (2006) 420-426
3. Behne D., Hilmert H., Scheid S., Gessner H., and Elger W. Evidence for specific selenium target tissues and new biologically important selenoproteins. Biochim. Biophys. Acta. 966 (1988) 12-21
4. Berggren M., Gallegos A., Gasdaska J.R., Gasdaska P.Y., Warneke J., and Powis G. Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia. Anticancer Res. 16 (1996) 3459-3466
5. Berry M.J. Insights into the hierarchy of selenium incorporation. Nat. Genet. 37 (2005) 1162-1163
6. Berry M.J., Banu L., Harney J.W., and Larsen P.R. Functional characterization of the eukaryotic SECIS elements which direct selenocysteine insertion at UGA codons. Embo. J. 12 (1993) 3315-3322
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
8. Bredfeldt T.G., Jagadish B., Eblin K.E., Mash E.A., and Gandolfi A.J. Monomethylarsonous acid induces transformation of human bladder cells. Toxicol. Appl. Pharmacol. 216 (2006) 69-79
9. Burns F.J., Rossman T., Vega K., Uddin A., Vogt S., Lai B., and Reeder R.J. Mechanism of selenium-induced inhibition of arsenic-enhanced UVR carcinogenesis in mice. Environ. Health Perspect. 116 (2008) 703-708
10. Copeland P.R., Fletcher J.E., Carlson B.A., Hatfield D.L., and Driscoll D.M. A novel RNA binding protein, SBP2, is required for the translation of mammalian selenoprotein mRNAs. EMBO J. 19 (2000) 306-314
11. de Jesus L.A., Hoffmann P.R., Michaud T., Forry E.P., Small-Howard A., Stillwell R.J., Morozova N., Harney J.W., and Berry M.J. Nuclear assembly of UGA decoding complexes on selenoprotein mRNAs: a mechanism for eluding nonsense-mediated decay?. Mol. Cell. Biol. 26 (2006) 1795-1805
12. Eblin K.E., Bredfeldt T.G., Buffington S., and Gandolfi A.J. Mitogenic signal transduction caused by monomethylarsonous acid in human bladder cells: role in arsenic-induced carcinogenesis. Toxicol. Sci. 95 (2007) 321-330
13. Eblin K.E., Bredfeldt T.G., and Gandolfi A.J. Immortalized human urothelial cells as a model of arsenic-induced bladder cancer. Toxicology 248 (2008) 67-76
14. Falkner K.C., McCallum G.P., Cherian M.G., and Bend J.R. Effects of acute sodium arsenite administration on the pulmonary chemical metabolizing enzymes, cytochrome P-450 monooxygenase, NAD(P)H:quinone acceptor oxidoreductase and glutathione S-transferase in guinea pig: comparison with effects in liver and kidney. Chem. Biol. Interact. 86 (1993) 51-68
15. Gailer J., George G.N., Pickering I.J., Madden S., Prince R.C., Yu E.Y., Denton M.B., Younis H.S., and Aposhian H.V. Structural basis of the antagonism between inorganic mercury and selenium in mammals. Chem. Res. Toxicol. 13 (2000) 1135-1142
16. Gailer J., George G.N., Pickering I.J., Prince R.C., Younis H.S., and Winzerling J.J. Biliary excretion of [(GS)(2)AsSe](-) after intravenous injection of rabbits with arsenite and selenate. Chem. Res. Toxicol. 15 (2002) 1466-1471
17. Ganyc D., Talbot S., Konate F., Jackson S., Schanen B., Cullen W., and Self W.T. Impact of trivalent arsenicals on selenoprotein synthesis. Environ. Health Perspect. 115 (2007) 346-353
18. Gladyshev V.N., Jeang K.T., Wootton J.C., and Hatfield D.L. A new human selenium-containing protein. Purification, characterization, and cDNA sequence. J. Biol. Chem. 273 (1998) 8910-8915
19. Hayflick L. The cell biology of aging. Clin. Geriatr. Med. 1 (1985) 15-27
20. Hayflick L., and Moorhead P.S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25 (1961) 585-621
21. He X., Chen M.G., Lin G.X., and Ma Q. Arsenic induces NAD(P)H-quinone oxidoreductase I by disrupting the Nrf2 × Keap1 × Cul3 complex and recruiting Nrf2 × Maf to the antioxidant response element enhancer. J. Biol. Chem. 281 (2006) 23620-23631
22. Hintze K.J., Keck A.S., Finley J.W., and Jeffery E.H. Induction of hepatic thioredoxin reductase activity by sulforaphane, both in Hepa1c1c7 cells and in male Fisher 344 rats. J. Nutr. Biochem. 14 (2003) 173-179
23. Hintze K.J., Wald K.A., Zeng H., Jeffery E.H., and Finley J.W. Thioredoxin reductase in human hepatoma cells is transcriptionally regulated by sulforaphane and other electrophiles via an antioxidant response element. J. Nutr. 133 (2003) 2721-2727
24. Holmgren A. Bovine thioredoxin system. Purification of thioredoxin reductase from calf liver and thymus and studies of its function in disulfide reduction. J. Biol. Chem. 252 (1977) 4600-4606
25. Kenyon E.M., Del Razo L.M., Hughes M.F., and Kitchin K.T. An integrated pharmacokinetic and pharmacodynamic study of arsenite action 2. Heme oxygenase induction in mice. Toxicology 206 (2005) 389-401
26. Kenyon E.M., Hughes M.F., Adair B.M., Highfill J.H., Crecelius E.A., Clewell H.J., and Yager J.W. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in C57BL6 mice following subchronic exposure to arsenate in drinking water. Toxicol. Appl. Pharmacol. 232 (2008) 448-455
27. Laurent T.C., Moore E.C., and Reichard P. Enzymatic synthesis of deoxyribonucleotides. Iv. Isolation and characterization of thioredoxin, the hydrogen donor from Escherichia coli B. J. Biol. Chem. 239 (1964) 3436-3444
28. Levander Q.A. Metabolic interrelationships between arsenic and selenium. Environ. Health Perspect. 19 (1977) 159-164
29. Levander Q.A., and Argrett L.C. Effects of arsenic, mercury, thallium, and lead on selenium metabolism in rats. Toxicol. Appl. Pharmacol. 14 (1969) 308-314
30. Li J., Waters S.B., Drobna Z., Devesa V., Styblo M., and Thomas D.J. Arsenic (+ 3 oxidation state) methyltransferase and the inorganic arsenic methylation phenotype. Toxicol. Appl. Pharmacol. 204 (2005) 164-169
31. Lin S., Cullen W.R., and Thomas D.J. Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase. Chem. Res. Toxicol. 12 (1999) 924-930
32. Lin S., Del Razo L.M., Styblo M., Wang C., Cullen W.R., and Thomas D.J. Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes. Chem. Res. Toxicol. 14 (2001) 305-311
33. Liu S.X., Athar M., Lippai I., Waldren C., and Hei T.K. Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 1643-1648
34. Low S.C., Grundner-Culemann E., Harney J.W., and Berry M.J. SECIS-SBP2 interactions dictate selenocysteine incorporation efficiency and selenoprotein hierarchy. Embo. J. 19 (2000) 6882-6890
35. Lu J., Chew E.H., and Holmgren A. Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 12288-12293
36. Moskovitz J. Roles of methionine suldfoxide reductases in antioxidant defense, protein regulation and survival. Curr. Pharm. Des. 11 (2005) 1451-1457
37. Moxon A. The influence of arsenic on the toxicity of seleniforous grains. Science (1938) 81
38. Nickson R., McArthur J., Burgess W., Ahmed K.M., Ravenscroft P., and Rahman M. Arsenic poisoning of Bangladesh groundwater. Nature 395 (1998) 338
39. Papp L.V., Lu J., Holmgren A., and Khanna K.K. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid. Redox. Signal. 9 (2007) 775-806
40. Petrick J.S., Ayala-Fierro F., Cullen W.R., Carter D.E., and Vasken Aposhian H. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 163 (2000) 203-207
41. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic. Acids. Res. 29 (2001) e45
42. Place R.F., Noonan E.J., and Giardina C. HDACs and the senescent phenotype of WI-38 cells. BMC Cell Biol. 6 (2005) 37
43. Pi J., Qu W., Reece J.M., Kumagai Y., and Waalkes M.P. Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: involvement of hydrogen peroxide. Exp. Cell. Res. 290 (2003) 234-245
44. Rhee S.G., Chae H.Z., and Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 38 (2005) 1543-1552
45. Rundlof A.K., Carlsten M., and Arner E.S. The core promoter of human thioredoxin reductase 1: cloning, transcriptional activity, and Oct-1, Sp1, and Sp3 binding reveal a housekeeping-type promoter for the AU-rich element-regulated gene. J. Biol. Chem. 276 (2001) 30542-30551
46. Small-Howard A., Morozova N., Stoytcheva Z., Forry E.P., Mansell J.B., Harney J.W., Carlson B.A., Xu X.M., Hatfield D.L., and Berry M.J. Supramolecular complexes mediate selenocysteine incorporation in vivo. Mol. Cell. Biol. 26 (2006) 2337-2346
47. Smith A.D., and Levander O.A. High-throughput 96-well microplate assays for determining specific activities of glutathione peroxidase and thioredoxin reductase. Methods Enzymol. 347 (2002) 113-121
48. Styblo M., M., and Thomas D.J. Selenium modifies the metabolism and toxicity of arsenic in primary rat hepatocytes. Toxicol. Appl. Pharmacol. 172 (2001) 52-61
49. Styblo M., Del Razo L.M., Vega L., Germolec D.R., LeCluyse E.L., Hamilton G.A., Reed W., Wang C., Cullen W.R., and Thomas D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74 (2000) 289-299
50. Talbot S., Nelson R., and Self W.T. Arsenic trioxide and auranofin inhibit selenoprotein synthesis: implications for chemotherapy for acute promyelocytic leukaemia. Br. J. Pharmacol. 154 (2008) 940-948
51. Thomas D.J., Li J., Waters S.B., Xing W., Adair B.M., Drobna Z., Devesa V., and Styblo M. Arsenic (+ 3 oxidation state) methyltransferase and the methylation of arsenicals. Exp. Biol. Med. (Maywood) 232 (2007) 3-13
52. Thomas D.J., Waters S.B., and Styblo M. Elucidating the pathway for arsenic methylation. Toxicol. Appl. Pharmacol. 198 (2004) 319-326
53. Wang C., and Lazarides E. Arsenite-induced changes in methylation of the 70,000 dalton heat shock proteins in chicken embryo fibroblasts. Biochem. Biophys. Res. Commun. 119 (1984) 735-743
54. Wang T.C., Jan K.Y., Wang A.S., and Gurr J.R. Trivalent arsenicals induce lipid peroxidation, protein carbonylation, and oxidative DNA damage in human urothelial cells. Mutat. Res. 615 (2007) 75-86
55. Wang X.J., Sun Z., Chen W., Eblin K.E., Gandolfi J.A., and Zhang D.D. Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity. Toxicol. Appl. Pharmacol. 225 (2007) 206-213
56. Yoo M.H., Xu X.M., Carlson B.A., Patterson A.D., Gladyshev V.N., and Hatfield D.L. Targeting thioredoxin reductase 1 reduction in cancer cells inhibits self-sufficient growth and DNA replication. PLoS. ONE. 2 (2007) e1112
57. Zhang J., Svehlikova V., Bao Y., Howie A.F., Beckett G.J., and Williamson G. Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation. Carcinogenesis 24 (2003) 497-503